Efficacy of Electroacupuncture Versus Solifenacin Succinate for Female Overactive Bladder

Launched by YIN PING · Mar 23, 2023

Keywords

ClinConnect Summary

This clinical trial is investigating the effectiveness of electroacupuncture as a treatment for overactive bladder (OAB) in women, compared to a medication called Solifenacin Succinate. OAB is a condition that causes a frequent urge to urinate, which can be quite bothersome. The study will involve women aged 18 to 75 who have been diagnosed with OAB for at least three months. To participate, women should not have had any previous acupuncture treatments and must not have serious health issues that could complicate the study.

If you qualify and decide to participate, you will receive either electroacupuncture or the medication, and researchers will monitor your progress. The trial is currently recruiting participants, so if you or someone you know is experiencing symptoms of OAB and meets the eligibility requirements, this could be an opportunity to help find new treatment options. Your participation could contribute valuable information to help others facing similar challenges.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Meet the American Urological Association (AUA) diagnostic criteria for adult overactive bladder disorder (non-neurogenic) and the Chinese Urological Association's Guidelines for the Diagnosis and Treatment of Urological Diseases in China (2014 edition) for OAB.
• • Female patients aged 18-75 years.
• • Duration of illness with OAB ≥ 3 months.
• • 3≤OABSS≤11.
• • No abnormality in routine urine tests.
• • Patients had never received acupuncture treatment.
• • No mental or intellectual abnormalities, able to understand the provisions of the scales and complete the assessment.
• • Consent to participate in this study and sign a written informed consent.
• Exclusion Criteria:
• • Combination of more serious heart, liver, kidney and other serious diseases; Or patients with severe liver or kidney insufficiency.
• • Patients with pelvic organ prolapse ≥ Ⅱ degree, urinary system surgery history or pelvic floor surgery history.
• • Patients with other diseases presenting with OAB symptoms.
• • Those with urinary diseases (such as calculi and tuberculosis of the bladder), malignant tumors, and neurological disorders.
• • Patients who are pregnant or breastfeeding.
• • Patients using medication that may affect bladder function one month prior to enrollment or having received behavioural therapy for OAB three months prior to enrolment, etc.
• • Patients with pacemakers.
• • Patients with blood diseases, diabetes mellitus or mental diseases.
• • Infections, ulcers, abscesses, and skin infections at needling sites; metal allergy or extreme needle phobia.
• • Participation in other clinical medical trial studies over the last month.